Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||
| Equity | Common Stock, par value $0.001 per share | |||||||||||||
To be issued pursuant to the Cogent Biosciences, Inc. Inducement Award Non-Qualified Stock Option Agreement (the “Inducement Options”) | 457(a) | 525,000 | $8.22(2) | $4,315,500(2) | $ 147.60 per $1,000,000 | $636.97 | ||||||||
| To be issued pursuant to the Cogent Biosciences, Inc. Inducement Restricted Stock Unit Award Agreement (the “Inducement RSUs”) | 457(a) | 214,000 | $9.60(3) | $2,054,400(3) | $ 147.60 per $1,000,000 | $303.23 | ||||||||
Total Offering Amounts | 739,000 | $6,369,900 | $940.20 | |||||||||||
Total Fee Offsets | $0 | |||||||||||||
Net Fee Due | $940.20 | |||||||||||||
| (1) | In addition to the number of shares of the common stock, par value $ 0.001 per share (the “Common Stock”), of the Registrant stated above, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers any additional shares of Common Stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of Common Stock. |
| (2) | Calculated pursuant to 457(h) under the Securities Act based on $ 8.22 , the exercise price per share of the Inducement Options. |
| (3) | The price of $ 9.60 per share, which is the average of the high and low sale prices of the Common Stock of the Registrant as quoted on the Nasdaq Global Select Market on July 31, 2024, is set forth solely for purposes of calculating the registration fee pursuant to Rules 457(c) and (h) of the Securities Act and has been used as these shares are without a fixed price. |
